Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Hanover › NPI 1730158981
Hospital

UPMC Hanover

UPMC Hanover was paid $2.92M by Medicaid between Apr 2018 and Dec 2024, across 153 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.

33Billing provider infoUPMC HANOVER
HANOVER, PA 17331
33aNPI1730158981assigned 03/17/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.92M
24GClaims105,118
24DCodes billed153
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#77 of 154
Median peer was paid$2.82M
This provider vs. median1.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201881$7K
2019113$2K
202010,163$271K
202149,660$1.23M
202211,920$369K
202317,752$505K
2024incomplete15,429$532K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 33% 9,778 9,443 $971K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 5,680 5,512 $410K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 6.3% 1,397 1,336 $184K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 6.2% 6,165 1,597 $180K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3.2% 1,108 1,069 $92K
80053 Comprehensive metabolic panel 2.6% 7,387 6,871 $77K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.5% 482 455 $73K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 2,511 2,337 $65K
G0378 Hospital observation service, per hour 2.2% 135 127 $64K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2.1% 11,298 10,634 $61K
80050 General health panel 1.7% 1,135 1,109 $50K
X0621 1.6% 245 123 $47K
141 more codes
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1.6% 1,609 $46K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.1% 3,204 $32K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 520 $27K
80061 Lipid panel <1% 1,902 $27K
71046 Radiologic examination, chest; 2 views <1% 1,962 $26K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 429 $25K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 711 $24K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 661 $22K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 585 $18K
84443 Thyroid stimulating hormone (TSH) <1% 817 $18K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 365 $18K
80048 Basic metabolic panel (calcium, ionized) <1% 2,159 $17K
70450 Computed tomography, head or brain; without contrast material <1% 316 $16K
77067 Screening mammography, bilateral, including computer-aided detection <1% 200 $16K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 371 $15K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 182 $14K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 221 $14K
96375 Therapeutic injection; each additional sequential IV push <1% 813 $13K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,471 $11K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 785 $11K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 454 $10K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 379 $9K
84703 <1% 989 $9K
84484 <1% 944 $9K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 380 $8K
83036 Hemoglobin; glycosylated (A1C) <1% 1,139 $8K
96361 Intravenous infusion, hydration; each additional hour <1% 722 $8K
83605 <1% 1,061 $8K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 184 $6K
71275 Computed tomographic angiography, chest, with contrast material <1% 37 $6K
81001 <1% 2,109 $6K
84702 <1% 356 $5K
83880 <1% 175 $5K
83735 <1% 948 $5K
82728 <1% 475 $5K
83690 <1% 1,059 $5K
86803 <1% 257 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,539 $4K
93971 <1% 84 $4K
87150 <1% 103 $4K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 191 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 146 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 197 $4K
87186 <1% 487 $4K
85027 <1% 585 $4K
80081 <1% 42 $4K
84439 <1% 435 $3K
71250 <1% 54 $3K
83540 <1% 451 $3K
87081 <1% 525 $3K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 606 $3K
82570 <1% 409 $3K
82607 <1% 242 $3K
85610 <1% 810 $3K
71045 Radiologic examination, chest; single view <1% 401 $3K
80076 <1% 297 $2K
86850 <1% 304 $2K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 107 $2K
85379 <1% 205 $2K
82043 <1% 242 $2K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 225 $2K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 12 $2K
87631 <1% 13 $2K
83550 <1% 375 $2K
87040 <1% 100 $1K
73610 <1% 82 $1K
87088 <1% 193 $1K
82784 <1% 84 $1K
74018 <1% 120 $1K
93017 <1% 40 $1K
86900 <1% 330 $1K
12001 <1% 13 $1K
86901 <1% 322 $1K
85652 <1% 402 $1K
84403 <1% 38 $1K
82950 <1% 156 $1K
86140 <1% 374 $1K
84550 <1% 156 $1K
87077 <1% 144 $979.96
76642 <1% 27 $849.28
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 201 $837.88
73630 <1% 71 $726.66
76536 <1% 15 $709.74
86038 <1% 44 $654.34
87340 <1% 40 $590.24
84481 <1% 25 $528.96
85730 <1% 99 $512.83
87205 <1% 115 $508.40
84100 <1% 102 $501.33
76830 Ultrasound, transvaginal <1% 12 $496.58
96376 <1% 66 $470.40
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,034 $468.61
85014 <1% 147 $447.68
82565 <1% 70 $443.67
85018 <1% 145 $441.41
J3490 Unclassified drugs <1% 602 $417.09
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 19 $370.03
J2704 Injection, propofol, 10 mg <1% 571 $347.12
73564 <1% 16 $300.54
99000 <1% 48 $288.00
86618 <1% 13 $284.85
73130 <1% 25 $276.80
86317 <1% 12 $272.48
84156 <1% 62 $250.12
86592 <1% 58 $249.20
83615 <1% 33 $246.29
80143 <1% 32 $237.12
83993 <1% 12 $236.97
80179 <1% 29 $225.18
83516 <1% 55 $214.92
87070 <1% 31 $212.96
82150 <1% 40 $200.75
J2270 Injection, morphine sulfate, up to 10 mg <1% 611 $189.61
36415 Collection of venous blood by venipuncture <1% 213 $184.28
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,541 $164.98
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,200 $163.90
87329 <1% 13 $161.91
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 26 $160.07
83525 <1% 13 $138.60
94060 <1% 13 $114.57
86430 <1% 12 $93.80
87045 <1% 13 $90.43
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 507 $81.99
J3010 Injection, fentanyl citrate, 0.1 mg <1% 475 $80.13
87046 <1% 13 $54.92
81025 <1% 14 $50.80
81003 <1% 13 $38.96
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 850 $35.28
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 620 $34.57
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 328 $17.85
J3475 Injection, magnesium sulfate, per 500 mg 0% 273 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 13 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 40 $0.00
J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg 0% 33 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 40 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 32 $0.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 0% 107 $0.00
J2060 Injection, lorazepam, 2 mg 0% 61 $0.00
A9573 Injection, gadopiclenol, 1 ml 0% 53 $0.00
A9585 Injection, gadobutrol, 0.1 ml 0% 151 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 0% 56 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMITSTIFER, GREGORY (CFO)
Same official

Other billing entities under MITSTIFER, GREGORY

Full network →
ProviderLocationPaid
UPMC Pinnacle HospitalsHarrisburg, PA$26.92M
UPMC MemorialYork, PA$6.74M
UPMC CarlisleCarlisle, PA$3.56M
UPMC LititzLititz, PA$2.49M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.